Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05563610 · ClinicalTrials.gov registry record · Phase 4
Oral Penicillin Challenge and Allergy De-labeling in Children
A Phase 4 study, sponsored by Phoenix Children's Hospital.
- Terminated
- Registry status
- Phase 4
- Development phase
- 31
- Enrollment target
NCT05563610: Clinical Trial Phase 4 study, sponsored by Phoenix Children's Hospital.
NCT05563610 is a Phase 4 study that was terminated before completion, run by Phoenix Children's Hospital. The registered enrollment target is 31 participants, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (94% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05563610, a Phase 4 study, was terminated before completion, sponsored by Phoenix Children's Hospital.
- TERMINATED
- Registry status
- Phase 4
- Development phase
- 31 participants
- Enrollment target
Study Summary
The primary purpose of this study is to investigate the portion of penicillin allergy labels that are not true allergies using oral amoxicillin challenges among pediatric patients. The secondary purpose is to evaluate the safety and feasibility of administering oral penicillin allergy challenges in the Pediatric Emergency Department.
Primary Outcome
Percentage of study patients presenting to the pediatric ED who received the amoxicillin oral challenge who demonstrated a true IgE-mediated allergic reaction
Interventions
- DRUG Amoxicillin 500mg
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 31 participants |
| Start Date | 2022-09-26 |
| Est. Completion | 2024-06-12 |
| Phase | Phase 4 |
Why NCT05563610 stopped before completion
NCT05563610 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 31 participants, a relatively small participant target, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (94% lower).
The record links to 0 conditions, and to 1 intervention - of which Amoxicillin 500mg is the first listed.
NCT05563610 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05563610 about?
NCT05563610 is a clinical study titled "Oral Penicillin Challenge and Allergy De-labeling in Children". The primary purpose of this study is to investigate the portion of penicillin allergy labels that are not true allergies using oral amoxicillin challenges among pediatric patients. The secondary purpose is to evaluate the safety and feasibility of administering oral penicillin allergy challenges in ...
What is the current status of trial NCT05563610?
This trial is currently terminated. It is a Phase 4 study. The enrollment target is 31 participants. The study started on 2022-09-26. Estimated completion is 2024-06-12.
What interventions are being tested in trial NCT05563610?
The interventions under investigation include: Amoxicillin 500mg (DRUG).
Who is sponsoring clinical trial NCT05563610?
This trial is sponsored by Phoenix Children's Hospital, which has 26 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT05563610's enrollment target sits among peer trials
31 1544th of 2000 higher than 449 of 2,000 other Phase 4 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 4 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02932618 · 31 participants · Phase 3
A Study of Recombinant Von Willebrand Factor (rVWF) With or Without ADVATE in Children With Severe Von Willebrand Disease (VWD)
- NCT03482297 · 31 participants · Phase 1
Automated Abdominal Binder for Orthostatic Hypotension
- NCT04016389 · 31 participants · NA
FIGO 2018 Stage IB2 Cervical Cancer Treated With Neoadjuvant Chemotherapy Followed by Fertility Sparing Surgery
- NCT04211675 · 31 participants · Phase 1
NK Cells Infusions With Irinotecan, Temozolomide, and Dinutuximab
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI